Concepedia

Author

Connie Lesnick

Mayo Clinic in ArizonaORCID

Also Known As

C E Lesnick, C.E. LESNICK, C.E. Lesnick, CONNIE LESNICK, Connie 1Lesnick, Connie E. Lesnick, Connie Lesnick

82

Publications

787

Citations

16

H-Index

26

Concepts

All Affiliations

Mayo Clinic in ArizonaMayo ClinicStanford UniversityMayo Clinic in FloridaWinnMed
CL

About

Connie Lesnick is an author at Mayo Clinic in Arizona specializing in medicine, immunology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

95

2

Immunology

4

4

95

3

Cell Biology

2

2

68

4

Allergy

1

1

16

5

Pathology

1

1

16

Connie Lesnick

×

15

Publications

566

Citations

13

H-Index

YearCitations

Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

Tait D. Shanafelt, Timothy G. Call, Clive S. Zent,

Cancer

2012

165

Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors

Sutapa Sinha, Justin C. Boysen, Michael Nelson,

Clinical Cancer Research

2015

72

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL

Sameer A. Parikh, Kari G. Rabe, Neil E. Kay,

Blood

2021

48

Sphingosine Kinase-1 Protects Multiple Myeloma from Apoptosis Driven by Cancer-Specific Inhibition of RTKs

Shuntaro Tsukamoto, Yuhui Huang, Motofumi Kumazoe,

Molecular Cancer Therapeutics

2015

39

Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

Victoria Wang, Curtis A. Hanson, Renee C. Tschumper,

Blood

2021

32

Progression and survival of MBL: a screening study of 10 139 individuals

Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach,

Blood

2022

30

Activation of natural killer cells in newborn piglets by interferon induction

Connie Lesnick, J.B. Derbyshire

Veterinary Immunology and Immunopathology

1988

29

Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Jeremy T. Larsen, Tait D. Shanafelt, José F. Leis,

American Journal of Hematology

2017

27

Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy

Helene Kretzmer, Anat Biran, Noelia Purroy,

Blood Cancer Discovery

2020

27

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease

Andrew McKeon, Connie Lesnick, Nisa Vorasoot,

Neurology Neuroimmunology & Neuroinflammation

2023

26

Page 1